Background: Hypertension and diabetes mellitus are interrelated diseases that affect an individual to be atherosclerotic disease. Hypertension is also associated with 30% mortality in patients with diabetes mellitus. Ineffective use of drugs an result in therapy failure and increase financing. Therefore, it is necessary to conduct a cost-effectiveness analysis in order to assist in making decisions on the selection of drugs that are effective in terms of benefits and costs.
Objective: To find out the cost-effectiveness value of therapy used by hypertensive patients with complications of type 2 DM who undergo hospitalization at RSI Aisyiyah Malang.
Method: This type of research is conducted observationally. Based on the time of data collection respectively, namely through secondary data tracing (patient medical record data). The design of this study is descriptive non-experimental with cross-sectional studies, namely by taking medical record data at a certain time. Sampling uses a non-probability method, namely purposive sampling.
Results and conclusions: The cost-effectiveness of drugs based on the most cost-effective ACER value is a combination of CCB + ARB drugs with ACER Rp. 44,364. The cost-effectiveness of drugs based on the most cost-effective ICER value is a combination of CCB + Diuretic drugs with an ICER value of Rp. 2,100
